Lightpoint Medical has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging (CLI). CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations.
Location: United Kingdom, England, Chesham
Employees: 11-50
Phone: +44 1494 917967
Total raised: $34.54M
Founded date: 2012
Investors 3
Funding Rounds 11
| Date | Series | Amount | Investors |
| 29.06.2021 | - | $8M | - |
| 26.03.2021 | Series A | $8M | - |
| 01.04.2019 | Grant | $1.18M | - |
| 06.12.2018 | - | $6.39M | - |
| 11.01.2017 | Grant | $1.22M | - |
| 06.08.2015 | Grant | $2.6M | - |
| 31.12.2014 | Series A | $3.12M | - |
| 25.11.2014 | Grant | $1.56M | - |
| 08.04.2014 | Grant | $1.8M | - |
| 04.02.2014 | Grant | $408.18K | - |
Show more
Mentions in press and media 13
| Date | Title | Description |
| 13.05.2025 | Telix Pharmaceuticals: Pioneering New Frontiers in Cancer Treatment | In the ever-evolving landscape of cancer treatment, Telix Pharmaceuticals is carving a niche. With its innovative approaches, the company is making strides in both diagnostic and therapeutic realms. Two recent developments showcase Telix's ... |
| 08.05.2025 | Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy | MELBOURNE, Australia and INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, h... |
| 04.03.2025 | Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum | MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company's late-stage and next-generation... |
| 21.06.2023 | Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical | MELBOURNE, Australia, June 21, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. L... |
| 18.09.2019 | 7 Medical Device Startups Revolutionising Healthcare | 1 shares Share Tweet Pin LinkedIn Medical device startups are big money: billions of dollars of venture funding pour in every year, and every major tech company is exploring the healthcare possibilities of wearables and mobile devices.... |
| 07.12.2018 | Lightpoint Medical secures £5 million for product commercialisation | Lightpoint Medical secures £5 million for product commercialisation 07-12-2018 Lightpoint Medical, a leader in intraoperative molecular imaging and sensing, announced that the company has secured £5 million in equity finance to fuel the com... |
| 07.12.2018 | Lightpoint Medical secures £5 million for product commercialisation | Lightpoint Medical, a leader in intraoperative molecular imaging and sensing, announced that the company has secured £5 million in equity finance to fuel the company’s commercial growth. Investors included existing and new shareholders Camb... |
| 06.12.2018 | Lightpoint Medical Raises £5M in Equity Funding | Lightpoint Medical, a Chesham, England, UK-based provider of intraoperative molecular imaging and sensing solutions, secured £5m in equity funding. Backers included Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestor... |
| 04.10.2017 | 100th deal by Cambridge Capital group | 100th deal by Cambridge Capital group 04-10-2017 Cambridge Capital salutes its members, who have now made the 100th investment since the group's inception. Formed in October 2000 by entrepreneurs, founding members of Cambridge Capital group... |
| 06.08.2015 | Lightpoint Medical Receives $2.6M Grant from US National Cancer Institute | Lightpoint Medical, a Rickmansworth, United Kingdom- and Cambridge, Massachusetts-based medical device company specializing in imaging technologies, received an R01 grant of $2.6M from the US National Cancer Institute. The funding will supp... |
Show more